BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9384694)

  • 1. The molecular basis of carcinogenesis: understanding the cell cycle clock.
    Weinberg RA
    Cytokines Mol Ther; 1996 Jun; 2(2):105-10. PubMed ID: 9384694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
    Yu Q; Ciemerych MA; Sicinski P
    Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of the cell cycle in cancer.
    Sandhu C; Slingerland J
    Cancer Detect Prev; 2000; 24(2):107-18. PubMed ID: 10917130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
    Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
    Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
    Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
    Glassford J; Rabin N; Lam EW; Yong KL
    Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.
    Lodén M; Stighall M; Nielsen NH; Roos G; Emdin SO; Ostlund H; Landberg G
    Oncogene; 2002 Jul; 21(30):4680-90. PubMed ID: 12096344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F; Djakiew D
    Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implication of cell cycle regulating genes in carcinogenesis].
    Hanada N; Saya H
    Tanpakushitsu Kakusan Koso; 1995 Aug; 40(11):1713-20. PubMed ID: 7676032
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclins, CDKs and cancer.
    Pines J
    Semin Cancer Biol; 1995 Apr; 6(2):63-72. PubMed ID: 7647308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclins and breast cancer.
    Sutherland RL; Musgrove EA
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):95-104. PubMed ID: 15082921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle exit upon myogenic differentiation.
    Walsh K; Perlman H
    Curr Opin Genet Dev; 1997 Oct; 7(5):597-602. PubMed ID: 9388774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [G1-cyclin/Cdk and cancer].
    Takahashi H; Matsushime H
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1554-61. PubMed ID: 9279081
    [No Abstract]   [Full Text] [Related]  

  • 20. The cell cycle in growth and development: a special issue.
    Wilkins AS
    Bioessays; 1995 Jun; 17(6):469-70. PubMed ID: 7575487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.